Oxbridge Re Holdings Limited (NASDAQ:OXBR – Get Free Report) shares passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.89 and traded as high as $1.09. Oxbridge Re shares last traded at $0.9620, with a volume of 190,629 shares trading hands.
Analysts Set New Price Targets
Separately, Weiss Ratings cut Oxbridge Re from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, June 3rd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Oxbridge Re presently has an average rating of “Sell”.
Read Our Latest Stock Analysis on Oxbridge Re
Oxbridge Re Stock Performance
Oxbridge Re (NASDAQ:OXBR – Get Free Report) last released its quarterly earnings results on Saturday, February 14th. The insurance provider reported $0.02 earnings per share for the quarter. The business had revenue of $0.58 million during the quarter. Oxbridge Re had a negative return on equity of 33.33% and a negative net margin of 76.47%.
Institutional Trading of Oxbridge Re
Hedge funds have recently added to or reduced their stakes in the company. Virtu Financial LLC acquired a new stake in Oxbridge Re during the 3rd quarter worth approximately $32,000. International Assets Investment Management LLC acquired a new stake in Oxbridge Re during the 4th quarter worth approximately $39,000. J.W. Cole Advisors Inc. acquired a new stake in Oxbridge Re during the 3rd quarter worth approximately $59,000. Finally, Henrickson Nauta Wealth Advisors Inc. lifted its holdings in Oxbridge Re by 100.0% during the 4th quarter. Henrickson Nauta Wealth Advisors Inc. now owns 137,400 shares of the insurance provider’s stock worth $185,000 after purchasing an additional 68,700 shares during the last quarter. 5.64% of the stock is owned by institutional investors and hedge funds.
Oxbridge Re Company Profile
Oxbridge Re Holdings Limited (NASDAQ: OXBR) is a reinsurance holding company that provides capital solutions and risk-sharing arrangements to insurance carriers. Its core business centers on offering treaty reinsurance and structured transactions designed to help insurers manage underwriting exposures and optimize their capital efficiency. By leveraging tailored financing structures, Oxbridge Re enables clients to transfer segments of their in-force life and health insurance portfolios, freeing up capital for growth or other strategic initiatives.
The company’s products and services include quota share reinsurance, coinsurance, and loss portfolio transfers, each crafted to address specific balance sheet and earnings targets of cedents.
See Also
- Five stocks we like better than Oxbridge Re
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power
Receive News & Ratings for Oxbridge Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxbridge Re and related companies with MarketBeat.com's FREE daily email newsletter.
